Your browser is no longer supported. Please, upgrade your browser.
TMDX TransMedics Group, Inc. daily Stock Chart
TransMedics Group, Inc.
Index- P/E- EPS (ttm)-1.55 Insider Own1.60% Shs Outstand20.75M Perf Week-1.47%
Market Cap389.06M Forward P/E- EPS next Y-1.32 Insider Trans-59.61% Shs Float15.10M Perf Month8.82%
Income-32.00M PEG- EPS next Q-0.38 Inst Own72.70% Short Float10.16% Perf Quarter-21.88%
Sales21.10M P/S18.44 EPS this Y-14.10% Inst Trans3.15% Short Ratio12.17 Perf Half Y-29.22%
Book/sh3.00 P/B6.25 EPS next Y32.00% ROA-40.70% Target Price25.00 Perf Year-
Cash/sh4.26 P/C4.41 EPS next 5Y- ROE49.90% 52W Range15.74 - 31.54 Perf YTD-16.14%
Dividend- P/FCF- EPS past 5Y- ROI12.80% 52W High-40.55% Beta-
Dividend %- Quick Ratio6.60 Sales past 5Y- Gross Margin55.10% 52W Low19.09% ATR1.30
Employees92 Current Ratio7.30 Sales Q/Q80.00% Oper. Margin- RSI (14)52.31 Volatility8.88% 6.22%
OptionableNo Debt/Eq0.54 EPS Q/Q-55.30% Profit Margin- Rel Volume3.34 Prev Close17.58
ShortableYes LT Debt/Eq0.54 EarningsNov 06 BMO Payout- Avg Volume126.07K Price18.75
Recom2.00 SMA201.79% SMA503.35% SMA200-18.30% Volume421,316 Change6.66%
May-28-19Initiated Morgan Stanley Equal-Weight
May-28-19Initiated JP Morgan Overweight
May-28-19Initiated Cowen Outperform
May-28-19Initiated Canaccord Genuity Buy
Dec-09-19 08:58AM  TransMedics' OCS Technology Sees Success in Heart Transplant Zacks +5.10%
Dec-04-19 08:00AM  TransMedics Organ Care System (OCS) Technology Used in First U.S. Adult Human Heart Transplants From DCD Donors GlobeNewswire
Nov-06-19 07:30AM  TransMedics Reports Third Quarter 2019 Financial Results GlobeNewswire -10.85%
Nov-01-19 02:17PM  Are Investors Undervaluing TransMedics Group, Inc. (NASDAQ:TMDX) By 32%? Simply Wall St. +8.75%
Oct-23-19 04:05PM  TransMedics Announces Change to Time of Third Quarter 2019 Earnings Conference Call on Wednesday, November 6 GlobeNewswire
Oct-16-19 04:05PM  TransMedics to Report Third Quarter 2019 Financial Results on November 6, 2019 GlobeNewswire
Sep-17-19 01:45PM  When Will TransMedics Group, Inc. (NASDAQ:TMDX) Turn A Profit? Simply Wall St.
Aug-26-19 04:05PM  TransMedics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-21-19 05:35PM  David Abrams Keeps Boosting Camping World, Gains 2 New Holdings in 2nd Quarter
Aug-07-19 04:05PM  TransMedics Reports Second Quarter 2019 Financial Results GlobeNewswire
Aug-02-19 08:21AM  What Kind Of Shareholder Appears On The TransMedics Group, Inc.'s (NASDAQ:TMDX) Shareholder Register? Simply Wall St.
Jul-30-19 08:30AM  TransMedics Announces Successful Long Distance Retrieval and Transplantation of Donor Lungs from Hawaii Using Organ Care System (OCS) GlobeNewswire
Jul-25-19 04:05PM  TransMedics to Present at the 39th Annual Canaccord Genuity Global Growth Conference GlobeNewswire
Jul-17-19 04:05PM  TransMedics to Report Second Quarter 2019 Financial Results on August 7, 2019 GlobeNewswire
Jun-30-19 08:11AM  3 IPO Stocks With Plenty of Growth Ahead TipRanks
Jun-11-19 04:05PM  TransMedics Reports First Quarter 2019 Financial Results GlobeNewswire
02:30PM  TransMedics Group, Inc. to Host Earnings Call ACCESSWIRE
Jun-03-19 08:00AM  TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations of Cold Storage GlobeNewswire
May-30-19 04:05PM  TransMedics to Report First Quarter 2019 Financial Results on June 11, 2019 GlobeNewswire
May-06-19 04:15PM  TransMedics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire +10.52%
May-01-19 01:25PM  TransMedics Group IPO: What You Need To Know Benzinga
Transmedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. The company offers its products in the United States and internationally. Transmedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
UNITED THERAPEUTICS Corp10% OwnerDec 09Sale18.75500,0009,375,0002,053,240Dec 10 04:31 PM
Carey John FVP of OperationsNov 15Option Exercise0.281,2003361,200Nov 18 04:39 PM
Sullivan John FVP of Quality & EngineeringNov 15Option Exercise0.281,40039210,828Nov 18 04:38 PM
Weill DavidDirectorNov 11Buy17.0010,000170,00010,000Nov 13 05:05 PM